Insider Trading & Ownership - Transcode Therapeutics Inc. (RNAZ)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Transcode Therapeutics Inc.
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2023-09-28
Purchase		2023-10-02
4:39 pm		Transcode Therapeutics Inc.RNAZFitzgerald Thomas A
Chief Financial Officer		49,350$0.51$25,16956,318
(Direct)		View
2023-09-28
Purchase		2023-10-02
4:37 pm		Transcode Therapeutics Inc.RNAZDudley Robert Michael
Chief Executive Officer		98,000$0.51$49,980180,262
(Direct)		View
2023-06-20
Purchase		2023-06-22
6:23 pm		Transcode Therapeutics Inc.RNAZDudley Robert Michael
Chief Executive Officer		18,607$2.6154$48,66582,262
(Direct)		View
2023-06-09
Purchase(A)		2023-06-14
4:16 pm		Transcode Therapeutics Inc.RNAZDudley Robert Michael
Chief Executive Officer		19,000$2.76$52,44061,155
(Direct)		View
2023-06-09
Purchase		2023-06-13
4:16 pm		Transcode Therapeutics Inc.RNAZDudley Robert Michael
Chief Executive Officer		19,000$2.76$52,440912,114
(Direct)		View
2022-09-14
Purchase		2022-09-16
6:44 pm		Transcode Therapeutics Inc.RNAZDudley Robert Michael
Chief Executive Officer
10% Owner		20,000$1.15$23,000893,114
(Direct)		View
2022-06-16
Purchase		2022-06-17
4:01 pm		Transcode Therapeutics Inc.RNAZFitzgerald Thomas A
Chief Financial Officer		12,000$1.27$15,240139,377
(Direct)		View
2022-05-27
Purchase		2022-06-01
4:01 pm		Transcode Therapeutics Inc.RNAZDudley Robert Michael
Chief Executive Officer
10% Owner		30,000$1.8461$55,383873,114
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2023-05-19
Option Award		2023-05-19
8:09 pm		N/A
2033-05-18		Transcode Therapeutics Inc.RNAZManting Erik
Director		45,000$045,000
(Direct)		View
2023-05-19
Option Award		2023-05-19
8:08 pm		N/A
2033-05-18		Transcode Therapeutics Inc.RNAZMarquet Magda
Director		45,000$045,000
(Direct)		View
2023-05-19
Option Award		2023-05-19
8:07 pm		N/A
2033-05-18		Transcode Therapeutics Inc.RNAZFitzgerald Thomas A
Chief Financial Officer		300,000$0300,000
(Direct)		View
2023-05-19
Option Award		2023-05-19
8:06 pm		N/A
2033-05-18		Transcode Therapeutics Inc.RNAZDudley Robert Michael
Chief Executive Officer		735,000$0735,000
(Direct)		View
2023-05-19
Option Award		2023-05-19
8:06 pm		N/A
2033-05-18		Transcode Therapeutics Inc.RNAZCalais Philippe
Director		45,000$045,000
(Direct)		View
2023-05-10
Option Award		2023-05-10
6:13 pm		N/A
2033-05-09		Transcode Therapeutics Inc.RNAZManting Erik
Director		9,500$09,500
(Direct)		View
2023-05-10
Option Award		2023-05-10
6:12 pm		N/A
2033-05-09		Transcode Therapeutics Inc.RNAZMarquet Magda
Director		9,500$09,500
(Direct)		View
2023-05-10
Option Award		2023-05-10
6:10 pm		N/A
2033-05-09		Transcode Therapeutics Inc.RNAZCalais Philippe
Director		9,500$09,500
(Direct)		View
2022-12-12
Option Award		2022-12-14
8:13 pm		N/A
2032-12-11		Transcode Therapeutics Inc.RNAZFitzgerald Thomas A
Chief Financial Officer		100,000$0100,000
(Direct)		View
2022-12-12
Option Award		2022-12-14
8:11 pm		N/A
2032-12-11		Transcode Therapeutics Inc.RNAZDudley Robert Michael
Chief Executive Officer
10% Owner		135,000$0135,000
(Direct)		View
2022-12-12
Option Award		2022-12-14
8:10 pm		N/A
2027-12-11		Transcode Therapeutics Inc.RNAZMedarova Zdravka
Chief Technology Officer
10% Owner		60,000$060,000
(Direct)		View
2022-02-01
Option Award		2022-12-14
8:06 pm		N/A
2027-01-31		Transcode Therapeutics Inc.RNAZMedarova Zdravka
Chief Technology Officer
10% Owner		33,000$033,000
(Direct)		View
2022-06-22
Option Award		2022-06-22
8:27 pm		N/A
2032-06-21		Transcode Therapeutics Inc.RNAZCalais Philippe
Director		9,500$09,500
(Direct)		View
2022-06-22
Option Award		2022-06-22
8:25 pm		N/A
2032-06-21		Transcode Therapeutics Inc.RNAZMarquet Magda
Director		9,500$09,500
(Direct)		View
2022-06-22
Option Award		2022-06-22
8:24 pm		N/A
2032-06-21		Transcode Therapeutics Inc.RNAZManting Erik
Director		9,500$09,500
(Direct)		View
2022-03-01
Option Award		2022-03-02
6:12 pm		N/A
2032-02-29		Transcode Therapeutics Inc.RNAZFitzgerald Thomas A
Chief Financial Officer		52,000$052,000
(Direct)		View
2022-02-01
Option Award		2022-02-03
06:04 am		N/A
2031-01-31		Transcode Therapeutics Inc.RNAZFitzgerald Thomas A
Chief Financial Officer		33,000$033,000
(Direct)		View
2022-02-01
Option Award		2022-02-03
06:03 am		N/A
2031-01-31		Transcode Therapeutics Inc.RNAZDudley Robert Michael
Chief Executive Officer
10% Owner		135,000$0135,000
(Direct)		View

Ownership		2021-07-08
9:54 pm		N/A
N/A		Transcode Therapeutics Inc.RNAZDudley Robert Michael
Chief Executive Officer
10% Owner		0$01,661,965
(Direct)		View

Ownership		2021-07-08
9:53 pm		N/A
N/A		Transcode Therapeutics Inc.RNAZFitzgerald Thomas A
VP, Chief Financial Officer		0$0369,999
(Direct)		View

Ownership		2021-07-08
9:53 pm		N/A
N/A		Transcode Therapeutics Inc.RNAZMedarova Zdravka
10% Owner		0$01,674,096
(Direct)		View

Ownership		2021-07-08
9:53 pm		N/A
2030-12-01		Transcode Therapeutics Inc.RNAZManting Erik
Director		0$036,393
(Direct)		View

Ownership		2021-07-08
9:53 pm		N/A
N/A		Transcode Therapeutics Inc.RNAZCalais Philippe
Director		0$0163,770
(Direct)		View

Ownership		2021-07-08
9:52 pm		N/A
N/A		Transcode Therapeutics Inc.RNAZMoore Anna
10% Owner		0$01,613,440
(Direct)		View

Ownership		2021-07-08
9:52 pm		N/A
2031-01-05		Transcode Therapeutics Inc.RNAZMarquet Magda
Director		0$036,393
(Direct)		View
(A) Indicate amendment filing.